$PEII Tacks On Another 33%

Petron Energy II, Inc. Announces Acquisition of New Lease in Oklahoma
DALLAS, TX, Jul 26, 2013 (Marketwired via COMTEX) -- Petron Energy II, Inc. (OTCBB: PEII) announces acquisition of new lease in Oklahoma.

Petron Energy II, Inc., together with its subsidiaries, engages in the acquisition and development of properties for the production of crude oil and natural gas, transporting natural gas through its pipeline subsidiary and well servicing through its servicing subsidiary, in the United States.

Floyd Smith, President and CEO of Petron Energy II, Inc., states, "Recently we acquired the 200 acre 'Applegate' lease in Wagoner County, Oklahoma. Several possible reservoirs are present including the Pennsylvanian Dutcher, the Simpson Wilcox, Burgen, and Tyner sands."

Smith goes on to say, "This type of lease is congruent with our development plan, in that it has 'shallow' oil and gas potential which can be water/natural gas flooded for maximum production rates." Smith further states, "The Applegate lease is surrounded by the Dutcher reservoir, the Dutcher has been a proven oil and natural gas producing reservoir in the area since mid-1920 and is an excellent reservoir for flooding operations which is our specialty."

About Petron Energy II, Inc.:

Petron Energy II, Inc. is a Dallas-based, oil and gas exploration and production company. For further information on the Company, please visit our website www.petronenergyii.com.

Notice Regarding Forward-Looking Statements

$PEII Continues Its 2 Day Massive Rally

Petron Energy II, Inc. Reports Update on LaNina and Covenant Wells and Also Announces Additional 15% Production Increase From Several Wells in Its Oklahoma Properties
DALLAS, TX, Jul 25, 2013 (Marketwired via COMTEX) -- Petron Energy II, Inc. (OTCBB: PEII) announces update on early production progress of 2 new wells and a 15% increase from rework operations in Oklahoma.

Petron Energy II, Inc., together with its subsidiaries, engages in the acquisition and development of properties for the production of crude oil and natural gas, transporting natural gas through its pipeline subsidiary and well servicing through its servicing subsidiary, in the United States.

Floyd Smith, President and CEO of Petron Energy II, Inc. states "In our July 11, 2013 press release we stated, "After positive results from our swab test we scheduled sand fracture stimulation treatments on the Covenant #5 and the LaNina #2 and we expected production results in the next 10 days. We successfully fractured each well and recently put the wells online, and although it is still early each well is moving an acceptable level of fluid and we have an oil cut in our LaNina #2 well which is very positive. The LaNina well was the first well we put online and the Covenant #5 followed later."

Smith went on to say, "When we consider the historical production experienced from two adjacent wells (Potis and TJS wells), which produced from the same pay zone the LaNina and Covenant wells are producing from we are very encouraged by the potential production increase. The Potis well had initial production of 70BO/D and the TJS well had initial production of 50BO/D. While we are in the early stages of results for both the LaNina and Covenant wells, if each well experienced the type of production results as the Potis and TJS wells it would make our LaNina and Covenant wells the biggest producing wells in Petron II's history. We expect production results on the LaNina #2 and Covenant #5 very soon and will report results to the market as soon as they are available."

Smith further states, "In additional rework operations we realized a 15% increase in production, as we continue to rework more wells we expect more increases."

About Petron Energy II, Inc.: Petron Energy II, Inc. is a Dallas-based, oil and gas exploration and production company. For further information about the Company, please visit our website www.petronenergyii.com.

$SNDY Rocketing Higher On News

Solos Endoscopy, Inc

MacReport Media   "Press Releases"

Solos Endoscopy, Inc. (OTC PINK: SNDY)is pleased to announce thatthe CompanysMammoView(R)Breast EndoscopySystemcanaid ingivingwomenthe best prognosis for recovery bydetectingbreast cancerat an earlier stagethan conventional methods(http://www.solosendoscopy.com/ductoscope-sell-sheet-final.pdf).

Physicians using the MammoView(R)Breast Endoscopy System can detect cancerous cells at .25mm compared to 1cm using the average conventional screening methods. Micro endoscopic detection allows physicians to clearly see the boundary between healthy and abnormal tissue. As a result, the MammoView(R)canimprove the chances that breast cancer bedetectedat an early stage and treated successfully.

Solos Endoscopy believes that all women, not just the rich and famous, need to benefit from early detection of breast cancer. Womenfrom all walks of life need to know theiroptions for detecting and preventing breast cancer, short of a mastectomy. Breast cancer is the most common cancer among women in the world. Of the five million women expected to die from breast cancer in the next decade, 70 percent will live inunder developedcountries.

Too many womendiscover they have been diagnosed with"breast cancer"at a point when their options for treatment are limited. The importance of early detectiontotreatment is well-recognized for reducing women's chances of dying from breast cancer. Breast health awareness, is a given in this country, however, many insurance companies do notnormallycovermammary ductoscopyproceduresfor early detection.

It is well documented that early detection is crucial in the fight against breast cancer. The MammoView(R)System is designed to significantly reduce the detection time andI believe it is an essential tool for earlybreast cancer screeningand treatment,stated Bob Segersten, President of Solos Endoscopy, Inc.

The Solos MammoView(R)Breast Endoscopy System can help more womendetectearly signsof disease and thereby seek advice as to multiple treatment options that early detection canoffer. Experts at theBreast Health Global Initiative(http://portal.bhgi.org/Pages/Default.aspx)and elsewhere propose tiered guidelines for diagnosis and treatment based on what's suitable and affordable for a country or community.Solos Endoscopy supportsimplementing such guidelines nowand giving Women more options for the early screening and detection of breast cancer.

The Solos MammoView(R)Breast Endoscopy System employs advanced microendoscopes and optical technology which gives physicians sharp images of the milk ducts where the majority of breast cancer arises.Solos Endoscopy instruments are FDA approved. Upon Solos Endoscopys receipt of its ISO 13485 Certification, the Company will be able to place theCE Mark on its entire MammoView(R)instrument line which will allow the instrument line to be sold globally. Both Solos and Expert Resource believe the ISO 13485 Certification and CE Mark initiative will be completed within the next few months. The Company has posted its schedule on its website.

TheSolosMammoView(R)Breast Endoscopy System includesa Microendoscope, Introducer, Dilator Set, and Cytology Retrieval Kit. Solos Endoscopys New MammoView(R)Breast Endoscopy Brochure is available online atwww.solosendoscopy.com.

About Solos Endoscopy, Inc.:

Solos Endoscopy is celebrating its 25^thYear of providing quality innovative healthcare instruments to Hospitals across the Country. For more than 25 Years, from medical schools to hospitals, surgeons have trusted Solos Endoscopy todevelop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.

Additional information on its FDA approved products is available on the Company's website at:www.solosendoscopy.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company's Annual Report filing and other filings with the OTC Markets Group (available atwww.otcmarkets.com). The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.

Investor Relations

(617) 360-9719

SOURCE:Solos Endoscopy, Inc.

$SEEK Continues its Impressive Rally

$LQMT - Theres the Crowd and There is The One Who Calls It Before The Crowd - First To Alert $LQMT This Week

This stock was alerted two days ago to my subscribers at $.06.  I called for a move over $.20.  Can't be any more right.

http://pennystockgurus.blogspot.com/2013/07/lqmt-soars-75-higher-one-day-after-i.html

http://pennystockgurus.blogspot.com/2013/07/lqmt-time-for-reversal.html

$LQMT up 175% After I Called For A Bounce Two Days Ago

With $LQMT still falling this week I let my subscribers know that the stock was due for a reversal.  The price of $LQMT at the time?  $.06.

http://pennystockgurus.blogspot.com/2013/07/lqmt-time-for-reversal.html

No one wanted to buy it, and thats what we like here at pennystockgurus.  No one wanted to buy any of the other stocks we alerted last week either.  Wednesday 100% alert, Thursday 108%+ alert, Friday OTHM over 400%.  My long term alert issued first thing this week was LQMT.  In the alert I said a move to $.20 was coming.  Am I just that good?  It appears so as $LQMT has moved from $.06 to $.19 a share.

Congratulations to my subscribers who bought at $.06 before this move.

$LQMT Soars 75% Higher One Day After I Called For A Reversal

Nothing like the smell of a big up candle in the morning!  Subscribers were greeted with a big move higher today for LQMT.  The chart has reversed and big profits are to be had.  It's been a great couple of weeks at pennystockgurus.  We had 100% alert on Wednesday, 108%+ on Thursday, and Friday OTHM from $.0007 to over $.0045, a great alert.

On Monday I told subscribers to be ready for a reversal for LQMT.  Today the stock is up 75% and climbing.  We could be looking at just the start of a massive rally for this stock.  Congratulations to my subscribers and everyone making a profit here.

I like LQMT for further gains, this is just the beginning.